Zymeworks FY25 Review: From Milestone Volatility To 2026 Upside
Source: SeekingAlpha
2026-03-04 10:45:05 ET
Thesis
Read the full article on Seeking Alpha
For further details see:
Zymeworks FY25 Review: From Milestone Volatility To 2026 Upside
Zymeworks Inc.
NASDAQ: ZYME
ZYME Trading
-5.24% G/L:
$25.15 Last:
323,159 Volume:
$25.09 Open:
ZYME Latest News
March 02, 2026 06:10:00 am
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing
March 02, 2026 06:01:00 am
Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing
ZYME Stock Data
$1,697,666,774
73,882,368
0.51%
61
N/A
Biotechnology & Life Sciences
Healthcare
CA
Middletown
